Stay in touch with research developments featuring UB CTSI investigators and other newsworthy accomplishments from around the Buffalo Translational Consortium and the national Clinical and Translational Science Award network.
The Trial Innovation Network provides UB researchers with an opportunity to utilize the resources and experience available at 50-plus CTSA institutions across the United States.
The National Center for Advancing Translational Sciences (NCATS) commemorated its 10-year anniversary in December with a virtual event highlighting its first decade.
The 2022 CTSI Annual Forum will feature a high-profile keynote speaker and an address from UB’s new Vice President for Health Sciences and Dean, Jacobs School of Medicine and Biomedical Sciences.
The CTSI Translational Pilot Studies Program provides seed money to investigators to assist them in developing new technologies and therapeutics from the conceptual stage to clinical studies.
CTSI K Scholar Jason A. Sprowl, PhD, School of Pharmacy and Pharmaceutical Sciences, has received an NIH grant to lead an exploration of how tyrosine kinases affect the removal of drugs by the liver.
Recognized for 2021 Buffalo Translational Consortium Clinical Research Achievement Awards are award winner Liise K. Kayler, MD, and award finalists Brian Clemency, DO, and Steven E. Lipshultz, MD.
The UB CTSI Center for Biomedical Imaging Pilot Studies Program offers a new opportunity for researchers looking to embark on innovative imaging translational research.
